169 related articles for article (PubMed ID: 73215)
1. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.
Teger-Nilsson AC; Friberger P; Gyzander E
Scand J Clin Lab Invest; 1977 Sep; 37(5):403-9. PubMed ID: 73215
[TBL] [Abstract][Full Text] [Related]
2. The measurement of human plasma antiplasmin activity by radial diffusion assay.
Andes WA
Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
4. Plasmin inactivation in plasma.
Haselager EM; Goote TM; Vreeken J
Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the inhibition of plasmin in acidified human plasma.
Lijnen HR; Maes M; Castel M; Samama M; Collen D
Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
[TBL] [Abstract][Full Text] [Related]
7. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
Bangert K; Thorsen S
Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
9. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
Holvoet P; de Boer A; Verstreken M; Collen D
Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
[TBL] [Abstract][Full Text] [Related]
10. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
Sumi H; Takada Y; Takada A
Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
[No Abstract] [Full Text] [Related]
12. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
13. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Travis J; Salvesen G
Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
[TBL] [Abstract][Full Text] [Related]
14. Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
Purwin M; Bruzgo I; Markowska A; Midura-Nowaczek K
Pharmazie; 2009 Nov; 64(11):765-7. PubMed ID: 20099524
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
Anonick PK; Wolf B; Gonias SL
Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
[TBL] [Abstract][Full Text] [Related]
16. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
Yomtova VM; Stambolieva NA; Blagoev BM
Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a latex agglutination assay method for the determination of plasmin/alpha 2 plasmin inhibitor complex].
Murakami F; Iijima K; Nakamura K; Ikawa S
Rinsho Byori; 1994 Jun; 42(6):643-7. PubMed ID: 8051804
[TBL] [Abstract][Full Text] [Related]
18. The contribution of plasma protease inhibitors to antiplasmin activity in man.
Crawford GP; Ogston D; Douglas AS
Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
[TBL] [Abstract][Full Text] [Related]
19. Blood inhibitory capacity toward exogenous plasmin.
Banbula A; Zimmerman TP; Novokhatny VV
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):241-6. PubMed ID: 17413760
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
Anonick PK; Yoo JK; Webb DJ; Gonias SL
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]